Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.10.0.1
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Revenue $ 254 $ 159 $ 630 $ 159
Operating expenses:        
Research and development (22,583) (7,434) (47,188) (17,258)
General and administrative (2,657) (1,021) (6,058) (3,152)
Total operating expenses (25,240) (8,455) (53,246) (20,410)
Operating loss (24,986) (8,296) (52,616) (20,251)
Interest (expense) / income, net (138) 123 (100) 169
Other (expense) / income, net 328 90 183 187
Total other (expense) / income 190 213 83 356
Loss before income taxes (24,796) (8,083) (52,533) (19,895)
Income tax expense (109) (88) (266) (393)
Net loss and comprehensive loss (24,905) (8,171) (52,799) (20,288)
Net loss attributable to ordinary shareholders $ (24,905) $ (8,171) $ (52,799) $ (20,288)
Net loss per share attributable to ordinary shareholders – basic and diluted $ (1.77) $ (44.16) $ (7.42) $ (127.42)
Weighted average ordinary shares outstanding – basic and diluted 14,034,631 185,040 7,115,655 159,221